Target
Lipoxygenase
Ligand
BDBM32020
Substrate
n/a
Meas. Tech.
ChEMBL_1715608 (CHEMBL4125657)
IC50
28000±n/a nM
Citation
 Ibrar, AShehzadi, SASaeed, FKhan, I Developing hybrid molecule therapeutics for diverse enzyme inhibitory action: Active role of coumarin-based structural leads in drug discovery. Bioorg Med Chem 26:3731-3762 (2018) [PubMed]  Article 
Target
Name:
Lipoxygenase
Synonyms:
n/a
Type:
PROTEIN
Mol. Mass.:
1886.07
Organism:
Glycine max
Description:
ChEMBL_103841
Residue:
18
Sequence:
PNSEEGLTCRGIPNSISI
  
Inhibitor
Name:
BDBM32020
Synonyms:
4-[4-(3,4-dihydroxyphenyl)-2,3-dimethyl-butyl]pyrocatechol | 4-[4-(3,4-dihydroxyphenyl)-2,3-dimethylbutyl]benzene-1,2-diol | 4-[4-[3,4-bis(oxidanyl)phenyl]-2,3-dimethyl-butyl]benzene-1,2-diol | BDBM166684 | CHEMBL52 | LOX inhibitor, N/A | MLS000069451 | NORDIHYDROGUAIARETIC ACID | Nordihydroguaiaretic acid (NDGA) | SMR000059049 | US10857082, Compound 2.18 | cid_4534
Type:
Small organic molecule
Emp. Form.:
C18H22O4
Mol. Mass.:
302.3649
SMILES:
CC(Cc1ccc(O)c(O)c1)C(C)Cc1ccc(O)c(O)c1
Structure:
Search PDB for entries with ligand similarity: